Income statement
SEK
Annual
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 78M | 87M | 75M | 91M | 83M |
| Gross Profit | 57M | 63M | 48M | 65M | 64M |
| Operating Income | -17M | -9M | -26M | -20M | -14M |
| EBITDA | 3M | -6M | -2M | -1M | -9M |
| Net Income | -20M | -8M | -26M | -22M | -13M |
| EPS (Diluted) | — | — | — | — | — |
Industrials
Live Price
Offline$0.18
+0.00% today
Window Change
+20.00%
Window
May 28, 2026 → Jun 18, 2026
Historical coverage is still filling in
This 1Y daily history view is currently sparse. Use it as directional context while we continue backfilling more history.
Coverage: 16 bars · May 28, 2026 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Precise Biometrics AB (publ) (PRBCF) is a Industrials stock with a market cap of $130.00M and listed on OTC. The stock last traded around $0.18 and up 20.0% across the available one-year price window (May 28, 2026 → Jun 18, 2026). Baseline metrics include revenue growth of -10.6%, EPS growth of -127.3%, a dividend yield of 0.0%. What stands out right now is revenue -10.6%, EPS -127.3%, free cash flow +151.2% with operating margin -25.2% and ROIC -13.5%. Valuation is more restrained than many high-expectation growth names at price/sales 1.7. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines PRBCF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Industrials peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
PRBCF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
PRBCF Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for PRBCF and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$83.3M
-8.5% YoY
FY Net Income
-$13.4M
+39.5% YoY
Free Cash Flow
-$21.1M
-18.3% YoY
Revenue Growth
-10.6%
EPS Growth
-127.3%
Gross Margin
72.8%
Net Margin
-25.6%
Income statement
SEK
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 78M | 87M | 75M | 91M | 83M |
| Gross Profit | 57M | 63M | 48M | 65M | 64M |
| Operating Income | -17M | -9M | -26M | -20M | -14M |
| EBITDA | 3M | -6M | -2M | -1M | -9M |
| Net Income | -20M | -8M | -26M | -22M | -13M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
SEK
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 18M | 38M | 48M | 46M | 64M |
| Total Assets | 174M | 203M | 213M | 213M | 241M |
| Total Liabilities | 43M | 52M | 53M | 67M | 113M |
| Shareholder Equity | 131M | 151M | 159M | 146M | 128M |
| Total Debt | 12M | 32M | 5M | 33M | 8M |
| Net Debt | -6M | -6M | -43M | -14M | -57M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
1M
-138.0% YoY
Capital Expenditures
20M
+9.9% YoY
Free Cash Flow
21M
-18.3% YoY
Key ratios
Gross Margin
72.8%
Operating Margin
-25.2%
Net Margin
-25.6%
ROE
-14.5%
Debt / Equity
0.09x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.